Malignant neoplasm of breast
ICD-10 C50 is a billable code used to indicate a diagnosis of malignant neoplasm of breast.
Malignant neoplasm of the breast, commonly referred to as breast cancer, encompasses a variety of tumors that arise from the breast tissue. The most prevalent type is invasive ductal carcinoma, which begins in the milk ducts and can spread to surrounding tissues. Breast cancer can be classified based on hormone receptor status, including estrogen receptor (ER) and progesterone receptor (PR) positivity, which significantly influences treatment options and prognosis. Additionally, the human epidermal growth factor receptor 2 (HER2) status is critical, as HER2-positive cancers may require targeted therapies such as trastuzumab. Staging of breast cancer is determined using the TNM system, which assesses tumor size (T), lymph node involvement (N), and presence of metastasis (M). Treatment protocols vary based on the stage and receptor status and may include surgery, radiation therapy, chemotherapy, and hormonal therapy. Early detection through mammography and clinical breast exams is vital for improving outcomes.
Detailed pathology reports, treatment plans, and follow-up notes.
Initial diagnosis, treatment planning, and follow-up care for breast cancer patients.
Ensure accurate coding of receptor status and staging to reflect treatment protocols.
Imaging reports, findings, and recommendations for further evaluation.
Mammography findings, breast ultrasound, and MRI evaluations.
Clear documentation of imaging findings related to breast lesions is essential.
Used when a patient undergoes a partial mastectomy for breast cancer treatment.
Operative report detailing the procedure and findings.
Oncology specialists should ensure accurate coding of the procedure in relation to the diagnosis.
Used when a needle biopsy is performed to confirm breast cancer diagnosis.
Pathology report confirming malignancy and biopsy details.
Radiologists must document imaging findings and biopsy results clearly.
Hormone receptor status is crucial for determining treatment options and prognosis. Accurate coding of this status ensures appropriate management and reflects the complexity of the disease.
Staging provides essential information about the extent of the disease, which influences treatment decisions and outcomes. Accurate staging is necessary for proper coding and reimbursement.
